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Research Article 
ABSTRACT 
Background: Aging process is often accompanied with some degree of decline in all the abilities, including learning and 
memory. One of the attracting research ﬁelds has been devoted to ﬁnding antiaging drugs. Metformin has shown some 
memory-enhancing features in aged humans and laboratory animals. Aims and Objective: To evaluate the effects of 50, 75, 
and 100 mg/kg of metformin on the spatial memory performance of aged rats in the Morris water maze. Materials and 
Methods: Thirty-two male 24-month-old rats were divided randomly into four groups (n = 8) including control group and 
50-, 75-, and 100-mg/kg metformin groups. After 36 days of treatment, the learning process was assessed by the reference 
memory task in the Morris water maze. All the rats received water maze training (four trials/day for 5 days) to assess the 
hippocampal-dependent spatial learning and, then, received a 60-s probe trial test of spatial memory retention 24 h after the 
twentieth trial. Result: Over 5 days of training, metformin (50, 75, and 100 mg/kg/day) treatment signiﬁcantly reduced the 
latency and path length to ﬁnd the escape platform (P o 0.01). In probe trials (without platform), on the last day of training, 
the metformin-treated groups spent signiﬁcantly longer time in the platform quadrant when compared with the control 
group. Among the treated groups, 100 mg/kg dosage of metformin induced the best rehearsals memory (P o 0.05). 
Conclusion: These results showed that, in the old rats, 36-day orally administered metformin showed a positive inﬂuence 
on the spatial memory performance in the Morris water maze. 
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||INTRODUCTION learning.[5] Of the various behavioral functions, Morris water 
maze (MWM) enables the analysis of spatial learning in rodents, 
A decline in the abilities, including cognition, has been considered which depends on distal cues to ﬁnd a way from the beginning 
as  the inevitable consequence  of  the aging  process.  Aging is point around the perimeter of an open swimming pool to identify 
characterized by cognitive decline, which actually presents as one the escape platform that is under water.
[5,6] Several studies have 
of the formidable features of aging.[1,2] Age-related deﬁcits in conﬁrmed its effectiveness in determining the spatial navigation 
different kinds of memory including spatial learning and memory that relies on the hippocampus.
[7] 
are widely reported.[1,3,4] A behavioral model often used to study The hippocampus is one of the brain areas involved in spatial 
the relationship between cognitive decline in rodents is spatial learning and memory.
[8] It has been suggested that the age-
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related decline in spatial-learning abilities is owing to the changes 
in the function and morphology of the hippocampal formation.[9] 
In the recent years, many research works have been 
devoted to ﬁnd drugs to postpone the beginning of cognitive 
decline in elderly persons. For example, to boost the spatial 
memory, a leading antidiabetic drug (i.e., metformin) has been 
examined and suggested.[10,11] A long-term treatment with 
metformin has been estimated to improve the health and 
lifespan in mice.[12]
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This study was undertaken to investigate the effects of 50, 
75, and 100 mg/kg of metformin on the spatial learning of aged 
rats using MWM task. 
MATERIALS AND METHODS 
Twenty-four-month-old rats weighing 400–450 g were obtained 
from the Aging Farm. They were housed two per cage in a 
temperature- (23 ± 1°C) and light (12-h light/dark schedule; 
lights on at 8:00 a.m.)-controlled environment and fed 
laboratory food and water ad libitum. All the protocols for the 
experiments on the animals were approved by the Research and 
Ethics Committee of Golestan University of Medical Sciences, 
Golestan, Iran. The animals were randomly divided into four 
groups of eight animals in each, including control group and 50-, 
75-, and 100-mg/kg metformin groups, respectively. Metformin 
was purchased from Sigma–Aldrich, dissolved in saline, and 
administrated via oral route for 36 days. Beginning on day 37, 
the spatial memory of rats in all the four groups was evaluated 
by MWM task. 
Morris Water Maze Task 
The MWM used in our study was a black circular pool (160 cm 
diameter, 60 cm high) ﬁlled with water (30 cm depth) at 24 ± 
2°C. The pool was divided into four quadrants arbitrarily 
designed northeast (NE), northwest (NW), southeast (SE), and 
southwest (SW) areas. A submerged Plexiglas platform (10 cm 
x 10 cm) was hidden 1 cm below the water surface and placed 
in a constant location in the center of NW quadrant. The animals 
received 5 days of training with the hidden platform; each day 
included four training sessions with a 60-s intersession interval. 
Each trial was started by placing a rat with its face toward the 
wall of the pool at one of the three start points. The start 
location was varied on each training trial and changed each day. 
The trial was terminated when the animal entered the platform. 
If the rat did not ﬁnd the platform within 60 s, it was placed on 
the platform by the experimenter for 15 s. During acquisition of 
the spatial navigation task, all the groups were given one 
session of four trials each day (days 1–5; trials 1–20). The 
spatial memory was evaluated in the probe trial. On the sixth 
day (trial 21), the platform was removed, and the animals were 
allowed to swim for 60 s. The path of the animals in the maze 
was monitored using a computerized video tracking system 
(Maze router, Urmia Instruments Inc). Parameters measured 
were the time taken to reach the platform (latency), swimming 
speed, and swim path length (SPL) in the training trials. 
Moreover, during the probe trials, the running time percentage 
within the quadrant of the water bath where the hidden 
platform had been placed in the training trials was calculated 
for each experimental animal. 
Statistical Analysis 
Data were analyzed using SPSS software, version 11.5, and 
plotted as mean ± SD. Comparison among the groups was 
made using analysis of variance (ANOVA) with a post hoc Tukey 
test or repeated-measures ANOVA. The results were considered 
signiﬁcantly different when P o 0.05 and highly signiﬁcantly 
different when P o 0.01. 
RESULT 
The escape latency and the distance traveled by the rats to 
ﬁnding the hidden platform in the water maze task are 
presented in Figures 1 and 2, respectively. The ability of all 
the experimental animals to ﬁnd the platform progressively 
improved over the 5 days of acquisition (P o 0.05). 
However, repeated-measures ANOVA of these data revealed 
that the performance on this task differed between the control 
group and each of the three metformin-treated groups in the 
ﬁrst four trial days (P o 0.01). Inspection of the data in these 
days showed that animals in the metformin-treated groups 
learned the task at a high rate, traveled a shorter distance, and 
spent less time to ﬁnd the escape platform than the control 
group (P o 0.01); but, on the ﬁnal trial day, the escape latency 
and path length were similar in all the experimental groups. 
Furthermore, in days 3 and 4, the 50-mg/kg dose of metformin 
showed better results when compared with the 75-mg/kg dose 
of metformin. But, the most effective dose of metformin for 
decreasing the escape latency and SPL in days 2, 3, and 4 of the 
trials was 100 mg/kg (P o 0.01). The analysis of swimming 
speed by using two-way ANOVA also showed no signiﬁcant 
difference as the training days progressed among the groups 
and no interaction between the days and the groups 
[Figure 1C]. 
Probe Trial 
Retention of the spatial training was assessed 24 h after the last 
training session with a 60-s free-swim probe trial using a new 
starting position. The parameters measured on the probe trial 
were the time spent in the quadrant containing the platform 
during training (target quadrant). Post hoc analysis showed 
that the metformin-treated groups showed signiﬁcantly differ­
ent experimental parameters from the control ones (P o 0.05, 
P o 0.01). The metformin-treated animals spent more time in 
the training quadrant when compared with the control animals 
in the 60-s probe trial [Figure 2]. In addition, among the treated 
groups, the 100-mg/kg/day group spent more time in the 
training quadrant (P o 0.01). Figure 3 shows representative 
plots (top view) of individual swim paths of one rat for each 
treatment group. It is obvious that, in the 100-mg/kg metformin 
group, the animal has spent most of its time in the target 
quadrant. 
DISCUSSION 
The results of this study suggest a spatial memory-enhancing 
role for metformin. Animals were treated for 36 days with three 
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Figure 1: Effect of 36 days of treatment with metformin on the performance of spatial memory acquisition phase in Morris water maze. Average 
escape latency (A), distance traveled (B) within each day (made up of four trials), and swimming speed within each day (made up of four trials) (C) 
are shown. Asterisks indicate a signiﬁcant difference from the control group (*P o 0.05, **P o 0.01). 
different doses of metformin, and their performance in a
 
reference memory task, MWM, was compared with controls.
 
The rats treated with 50-, 75-, and 100-mg/kg/day doses of
 
metformin performed better than the control group in the
 
water maze task. The latency and path length to ﬁnding
 
the escape platform signiﬁcantly reduced in the metformin­
treated animals. Surprisingly, on the ﬁrst day of testing, the
 
metformin-treated rats found the platform signiﬁcantly faster 
than the control animals, and they were consistently better at 
the task than the control group until the ﬁfth day of the trial. 
Some recent research reports suggest that adult hippocam­
pal neurogenesis is involved in hippocampus-mediated learning 
and memory. The two adult neurogenic regions, namely, the 
subventricular zone and the dentate gyrus show, in particular, a 
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Figure 2: Mean percentage (±SEM) of the time spent in target quadrant during probe trials. Asterisks indicate a signiﬁcant difference from control 
(*P o 0.05; **P o 0.01). 
Figure 3: Tracings of the typical swim patterns in the probe trials at the control (A) and 50- (B), 75- (C), and 100-mg/kg (D) metformin groups 
tested. The escape platform was on northwest quadrant. 
reduction in neurogenesis that is related to aging.[13] Metformin 
has increased the number of neurons generated in the dentate 
gyrus of rats,[14] and Wang et al.[10] have shown that metformin 
improves the ability to update new spatial memories, a task 
related to hippocampal neurogenesis. It seems reasonable that, 
in our experiments, metformin even at the dose as low as 50 
mg/kg/day for 36 days could stimulate hippocampal neurogen­
esis and prevent the spatial memory loss to some degree. On the 
other hand, it is a well-established fact that oxidative stress 
mechanisms have a prominent role in the aging process and 
make the neurons vulnerable to degeneration and development 
of neurodegenerative disorders.[15] Some researchers have 
proposed an antioxidant role for metformin.[16,17] Perhaps, 
metformin with its antioxidant effects could be beneﬁcial in 
preventing oxidative damage to the hippocampal neurons and 
improve the animals’ performance in the MWM task. The third 
possible mechanism of memory-enhancing feature of metformin 
may act via its interaction with brain neurotransmitter systems, 
especially cholinergic system. Bhutada et al.[18] showed that 
metformin inhibits acetylcholine esterase and, so, it can 
potentiate acetylcholine effect on the hippocampus cholinergic 
synapses. 
CONCLUSION 
A 36-day treatment with 50, 75, and 100 mg/kg/day doses of 
metformin signiﬁcantly improved the MWM task performance 
of aged rats, and the 100-mg/kg dose showed better results 
when compared with the two other doses. Exploring the exact 
mechanism of metformin memory-enhancing effect needs 
widespread research work. 
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